SLP
HEALTHCARESimulations Plus Inc
$15.88+0.17 (+1.08%)LIVE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving SLP Today?
No stock-specific AI insight has been generated for SLP yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$11.09$34.01
$15.88
Fundamentals
Market Cap$321M
P/E Ratio—
EPS$-3.12
Dividend Yield—
Dividend / Share—
ROE-0.4%
Profit Margin-0.8%
Debt / Equity—
Trading
Volume2.2M
Avg Volume (10D)—
Shares Outstanding20.2M
SLP News
22 articles- NVIDIA (NVDA): The Best Quality Stock to Buy and Hold for the Next 5 YearsYahoo Finance·May 9, 2026
- Simulations Plus and NVIDIA Collaborate to Scale GPU-Accelerated, AI-Assisted Modeling WorkflowsYahoo Finance·May 6, 2026
- Do Options Traders Know Something About Simulations Plus Stock We Don't?Yahoo Finance·May 4, 2026
- Global Biosimulation Market Poised for Phenomenal Expansion at a CAGR of ~17% by 2034 | DelveInsightGlobeNewswire Inc.·Apr 27, 2026
- Biosimulation Market Research and Global Forecast Report 2026-2036: Expansion Driven by Precision Medicine, AI-Powered In-Silico Drug Development and Rising Demand for Cost-Efficient Clinical TrialsYahoo Finance·Apr 22, 2026
- Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug ProductsYahoo Finance·Apr 21, 2026
- Badger Meter's Q1 Earnings & Revenues Miss Estimates, Stock DipsYahoo Finance·Apr 20, 2026
- Simulations Plus Expands Global Access to Model-Informed Drug Development Training Through Its 2026 Spring SchoolYahoo Finance·Apr 20, 2026
- Here’s Simulations Plus Inc (SLP)’s Vision for AI in Drug DevelopmentYahoo Finance·Apr 19, 2026
- How The Sylvania Platinum (AIM:SLP) Story Is Shifting As Valuation Tweaks Meet New GuidanceYahoo Finance·Apr 18, 2026
- Simulations Plus Q2 Earnings Call HighlightsMarketbeat·Apr 13, 2026
- Morning Movers: Organon jumps after report of Sun Pharmaceutical bidYahoo Finance·Apr 11, 2026
- Why Simulations Plus Stock Inched Higher TodayMotley Fool·Apr 10, 2026
- Simulations Plus Q2 Earnings & Revenues Beat, Jump Y/Y, Shares SoarYahoo Finance·Apr 10, 2026
- Simulations Plus, Inc. Q2 2026 Earnings Call SummaryMoby·Apr 10, 2026
- Stock Market Today: S&P 500 Futures Fall Ahead Of March CPI As Trump Says Iran Isn't Upholding Ceasefire—Taiwan Semiconductor, Rocket Lab In FocusBenzinga·Apr 10, 2026
- Simulations Plus Inc (SLP) Q2 2026 Earnings Call Highlights: Strong Revenue Growth Amidst ...Yahoo Finance·Apr 10, 2026
- Simulations Plus (SLP) Beats Q2 Earnings and Revenue EstimatesYahoo Finance·Apr 9, 2026
- Simulations Plus Reports Second Quarter Fiscal 2026 Financial ResultsYahoo Finance·Apr 9, 2026
- Undiscovered Gems In The United Kingdom To Watch April 2026Yahoo Finance·Apr 8, 2026
- How The Sylvania Platinum (AIM:SLP) Narrative Is Shifting With New Targets And DividendsYahoo Finance·Apr 3, 2026
- Simulations Plus and three pharma companies collaborate on AI-driven drug developmentPharmaceutical-technology·Mar 27, 2026
All 22 articles loaded
Price Data
Open$17.32
Previous Close$15.71
Day High$17.32
Day Low$14.82
52 Week High$34.01
52 Week Low$11.09
52-Week Range
$11.09$34.01
$15.88
Fundamentals
Market Cap$321M
P/E Ratio—
EPS$-3.12
Dividend Yield—
Dividend / Share—
ROE-0.4%
Profit Margin-0.8%
Debt / Equity—
Trading
Volume2.2M
Avg Volume (10D)—
Shares Outstanding20.2M
About Simulations Plus Inc
Simulations Plus, Inc. develops drug discovery and development software for mechanistic modeling, simulation, and prediction of molecule properties using artificial intelligence and machine learning technology worldwide. The company is headquartered in Lancaster, California.
HEALTHCAREHEALTH INFORMATION SERVICES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICHEALTH INFORMATION SERVICES
CIK—
Composite FIGI—
Share Class FIGI—